Drugs that contain Tirofiban Hydrochloride
1. List of Aggrastat drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6770660 | MEDICURE | Method for inhibiting platelet aggregation |
May, 2023
(a month ago) | |
Do you want to check out AGGRASTAT patents from before 2022?
Market Authorisation Date: 14 May, 1998
Treatment: A dosing regimen of aggrastat (tirofiban hydrochloride)(25mcg/kg followed by 0.15mcg/kg/min infusion) to reduce the rate of thrombotic coronary events associated with acute coronary syndrome (acs) in ...
Dosage: INJECTABLE;INJECTION; SOLUTION;INJECTION
How can I launch a generic of AGGRASTAT before it's patent expiration?
More Information on Dosage
AGGRASTAT family patents
8
United States
1
Canada
1
Japan
1
Australia
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic